Dreem: Beacon Biosignals Acquires Dreem

Beacon Biosignals, a Boston, MA-based computational neurodiagnostics and electroencephalogram (EEG) analytics company, acquired Dreem, a Paris, France-based company which specializes in at-home sleep monitoring. The amount of the deals as not disclosed. This strategic acquisition signifies a remarkable milestone, setting the stage for clinical trial assessments at scale via the integration of Dreem's clinically-validated hardware with [...]The post Beacon Biosignals Acquires Dreem appeared first on FinSMEs.